Quiz
Article
NeurologyLive® Brain Games: May 11, 2025
Author(s):
Key Takeaways
- NeurologyLive Brain Games offers weekly quizzes on diverse neurology topics, enhancing professional knowledge and engagement.
- The quiz series covers a wide range of neurological conditions, with a current focus on B-cell depleting medications for multiple sclerosis.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on B-cell depleting medications for MS.
Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions on a variety of clinical and historical neurology topics, written by physicians, clinicians, and experts in the fields of neurological care and advocacy.
Test your mettle each week with 3 questions that cover a variety of aspects in the field of neurology, with a focus on dementia and Alzheimer disease, epilepsy and seizure disorders, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke and cerebrovascular disease.
This week's questions include the theme of B-cell depleting medications for MS.
Click here to check out the prior iterations of Brain Games.
Interested in submitting quiz questions? Contact our editor, Marco Meglio, via email: mmeglio@neurologylive.com.
Which of the following B-cell depleting therapies is FDA-approved for both relapsing and primary progressive multiple sclerosis?
What is the primary mechanism by which B-cell depleting therapies like ocrelizumab and ofatumumab exert their effects in MS?
Which of the following is a known risk associated with B-cell depleting therapy in patients with MS?
How did you do on this week's quiz? Let us know with a response to the poll below. Don't forget to share and compare your results with your friends!
How many questions did you get correct?
